Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ARR
3326
Armour Residential REIT
ARR
$1.9B
| $366K | ﹤0.01% |
21,919
-165,622
| -88% | -$2.93M |
2013 Q2
51 quarters
|
|
3327
Peapack-Gladstone Financial
PGC
$788M
| $365K | ﹤0.01% |
10,369
-24,671
| -70% | -$802K |
2013 Q2
51 quarters
|
|
3328
MVB Financial
MVBF
$394M
| $365K | ﹤0.01% |
14,703
-14,918
| -50% | -$400K |
2018 Q2
31 quarters
|
|
|
EHAB
3329
DELISTED
Enhabit
EHAB
| $364K | ﹤0.01% |
25,842
-62,968
| -71% | -$754K |
2022 Q3
14 quarters
|
|
3330
BJ's Restaurants
BJRI
$1.3B
| $363K | ﹤0.01% |
10,339
-27,862
| -73% | -$1.11M |
2013 Q2
51 quarters
|
|
3331
Entrada Therapeutics
TRDA
$206M
| $362K | ﹤0.01% |
28,676
-38,471
| -57% | -$441K |
2022 Q1
16 quarters
|
|
3332
Bowman Consulting
BWMN
$738M
| $361K | ﹤0.01% |
12,701
-19,386
| -60% | -$632K |
2022 Q3
14 quarters
|
|
3333
Editas Medicine
EDIT
$387M
| $360K | ﹤0.01% |
145,602
-130,660
| -47% | -$277K |
2016 Q3
38 quarters
|
|
3334
NeoGenomics
NEO
$2.39B
| $357K | ﹤0.01% |
48,115
-177,063
| -79% | -$1.86M |
2015 Q2
43 quarters
|
|
|
HPP
3335
Hudson Pacific Properties
HPP
$620M
| $356K | ﹤0.01% |
60,195
-39,495
| -40% | -$303K |
2013 Q2
51 quarters
|
|
3336
Natural Gas Services Group
NGS
$435M
| $355K | ﹤0.01% |
9,412
-11,972
| -56% | -$438K |
2023 Q3
10 quarters
|
|
3337
Ameresco
AMRC
$1.15B
| $355K | ﹤0.01% |
13,909
-45,622
| -77% | -$1.37M |
2017 Q1
36 quarters
|
|
|
MBX
3338
MBX Biosciences
MBX
$2.83B
| $353K | ﹤0.01% |
11,838
-40,853
| -78% | -$1.39M |
2024 Q3
6 quarters
|
|
|
CEPO
3339
Cantor Equity Partners I
CEPO
$274M
| $352K | ﹤0.01% |
33,533
| – | – |
2025 Q4
1 quarter
|
|
3340
CALL
Fortinet
FTNT
$133B
| $351K | ﹤0.01% |
4,300
-129,600
| -97% | -$10.5M |
2023 Q2
11 quarters
|
|
3341
Viant Technology
DSP
$266M
| $351K | ﹤0.01% |
31,370
-24,605
| -44% | -$272K |
2022 Q1
16 quarters
|
|
3342
Delcath Systems
DCTH
$530M
| $351K | ﹤0.01% |
37,849
-40,638
| -52% | -$394K |
2024 Q3
6 quarters
|
|
3343
Riverview Bancorp
RVSB
$120M
| $351K | ﹤0.01% |
63,840
-22,391
| -26% | -$118K |
2022 Q3
14 quarters
|
|
3344
Genie Energy
GNE
$437M
| $350K | ﹤0.01% |
24,736
-28,850
| -54% | -$409K |
2022 Q3
14 quarters
|
|
|
AII
3345
American Integrity Insurance
AII
$508M
| $350K | ﹤0.01% |
18,130
-9,991
| -36% | -$190K |
2025 Q3
2 quarters
|
|
3346
iShares Global Consumer Staples ETF
KXI
$1.1B
| $348K | ﹤0.01% |
5,200
| – | – |
2020 Q4
21 quarters
|
|
3347
Skyward Specialty Insurance
SKWD
$2.45B
| $348K | ﹤0.01% |
7,970
-50,910
| -86% | -$2.31M |
2023 Q1
12 quarters
|
|
3348
Camtek
CAMT
$7.53B
| $348K | ﹤0.01% |
2,295
+1,493
| +186% | +$226K |
2023 Q2
11 quarters
|
|
3349
Sprout Social
SPT
$605M
| $347K | ﹤0.01% |
60,813
-43,988
| -42% | -$339K |
2022 Q1
16 quarters
|
|
|
JBIO
3350
Jade Biosciences
JBIO
$853M
| $346K | ﹤0.01% |
24,660
-47,534
| -66% | -$688K |
2022 Q1
16 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.